Cite
HARVARD Citation
Petrie, K. et al. (2020). Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer. Cancer reports. 3 (6), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Petrie, K. et al. (2020). Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer. Cancer reports. 3 (6), p. n/a. [Online].